Laurence de Leval
Laurence de Leval is Professor of Pathology and Head of the Clinical Pathology department at the University Hospital of Lausanne, Switzerland. She completed her M.D. at the University of Liège, Belgium, in 1994, where she also entered the Pathology residency programme and obtained a PhD in Experimental Pathology in 1998. She completed a 2-year postdoctoral fellowship in Hematopathology at Massachussetts General Hospital, Harvard Medical School, Boston, MA, USA. From 2000 to 2009 she was Staff Pathologist at Liège University Hospital and Senior Researcher at the Belgian National Fund for Scientific Research. In 2007, Laurence de Leval and Philippe Gaulard elucidated the cellular of origin of angioimmunoblastic T-cell lymphoma by reporting its derivation from a follicular helper T (TFH) cell. Prof de Leval continues research in that field, aiming to characterize of pathological spectrum of lymphomas derived from TFH cells, and decipher the molecular mechanisms underlying oncogenesis in NK/T-cell malignancies. Her lab was the first to demonstrate recurrent TET2 mutations in T-cell lymphomas. Her other research interests include the clinical and pathological characterization of lymphoma entities and other hematopoietic neoplasms, and implementing and optimizing tools for the molecular diagnosis of hematological malignancies and other cancers. She has authored more than 170 scientific publications and several chapters of textbooks in pathology and hematology. She is a member of the LYSA (Lymphoma Study Association) Executive Board and its Pathology group, and was elected Member of the International Lymphoma Study Group in 2011. She is a member of the International Thymic Malignancy Group (ITMIG). Her diagnostic activities are mainly in haematopathology and molecular pathology. She received the Benjamin Castleman award, presented by the USCAP, in 2008 and was awarded the Inbev-Baillet Latour Fund Prize for Clinical Research in 2009.